Popular thyroid drugs are recalled because pills are not strong enough

Acella Pharmaceuticals has announced the withdrawal of the popular thyroid treatment because tablets in lots called may not be as strong as expected. Assuming patients with hypothyroidism take sub-mogen drugs, their TSH levels can increase and the symptoms can return. The tablet remembered was labeled with a dose starting from 15 mg to 120mg.

Withdrawals involve thyroid NP, thyroid prescription medication prepared using the Porcine thyroid gland rather than synthetic T4 hormones. Routine testing, according to Acella Pharmaceuticals, found that some products are not as strong as the dosage labeled them with less than 90 percent of the number of registered T3 and / or T4 hormones.

Hypotheliroidism patients who take sub-migen thyroid drugs can see the return of their symptoms gradually, which can cover everything from dry skin and depression to thyroid and swollen weight weight. Other potential problems can also appear in some patients, such as heart problems in people who suffer from heart disease and initial miscarriages in pregnant women.

Acella explained that the withdrawn products are packaged in a 7-count bottle and 100 counts with doses labeled 15mg, 30mg, 60mg, 90mg, and 120mg. Lot thyroid NP remembered has been distributed throughout the US to the Health Office, pharmacy, and more. Patients who took one of the bottles drawn was advised to continue to take it until they contacted their doctor for replacement.

Thyroid NP users must consult with the graph included with the Notification of Acella to determine whether they are affected. This chart displays Lot numbers, expiration dates, distribution dates, and NDC numbers of drawn products, and round tablet images and product labels.